Neuroblastoma
Showing NaN - NaN of 61
Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)
Recruiting
- Colorectal Carcinoma
- +21 more
- Dual X-ray Absorptiometry
- +2 more
-
Birmingham, Alabama
- +18 more
Jan 30, 2023
Neuroblastoma Trial in Houston (GINAKIT Cells, Cyclophosphamide, Fludarabine)
Active, not recruiting
- Neuroblastoma
- GINAKIT Cells
- +2 more
-
Houston, TexasTexas Children's Hospital
Jan 18, 2023
Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Neuroblastoma Trial in Worldwide (Idasanutlin, Venetoclax,
Recruiting
- Acute Myeloid Leukemia (AML)
- +3 more
- Idasanutlin
- +6 more
-
Phoenix, Arizona
- +19 more
Jan 18, 2023
Neuroblastoma Trial in Houston (iC9-GD2 T Cells - frozen, iC9-GD2 T Cells - fresh, Cytoxan)
Active, not recruiting
- Neuroblastoma
- iC9-GD2 T Cells - frozen
- +5 more
-
Houston, Texas
- +1 more
Jan 4, 2023
Neuroblastoma, Medulloblastoma Trial in United States (Nifurtimox, Cyclophosphamide, Topotecan)
Completed
- Neuroblastoma
- Medulloblastoma
- Nifurtimox
- +2 more
-
San Diego, California
- +14 more
Dec 28, 2022
Ganglioneuroblastoma, Neuroblastoma Trial in Canada, Puerto Rico, United States (procedure, drug, biological, radiation)
Recruiting
- Ganglioneuroblastoma
- Neuroblastoma
- Autologous Hematopoietic Stem Cell Transplantation
- +18 more
-
Birmingham, Alabama
- +158 more
Sep 14, 2022
Neuroblastoma Trial in Worldwide (GM-CSF + Naxitamab)
Recruiting
- Neuroblastoma
- GM-CSF + Naxitamab
-
Gainesville, Florida
- +22 more
Aug 29, 2022
Neuroblastoma Trial in Worldwide (LY3295668 Erbumine, Topotecan, Cyclophosphamide)
Active, not recruiting
- Neuroblastoma
- LY3295668 Erbumine
- +2 more
-
San Francisco, California
- +21 more
Aug 17, 2022
Ganglioneuroblastoma, Nodular, Neuroblastoma Trial in Worldwide (Dinutuximab, Irinotecan, Isotretinoin)
Active, not recruiting
- Ganglioneuroblastoma, Nodular
- Neuroblastoma
- Dinutuximab
- +4 more
-
Mesa, Arizona
- +77 more
Aug 17, 2022
Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma Trial in Worldwide (Carboplatin,
Recruiting
- Ganglioneuroblastoma
- +3 more
- Carboplatin
- +6 more
-
Birmingham, Alabama
- +219 more
Aug 17, 2022
Recurrent or Refractory Solid Tumors, Ewing Sarcoma, Rhabdomyosarcoma Trial in United States (MM-398 (Irinotecan Sucrosofate
Recruiting
- Recurrent or Refractory Solid Tumors
- +4 more
- MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide
-
Cincinnati, Ohio
- +5 more
Mar 17, 2022
Neuroblastoma Trial in Houston (Neuroblastoma Vaccine (unmodified SKNLP, with gene-modified SJNB-JF-IL2 and SJNB-JF-LTN
Active, not recruiting
- Neuroblastoma
- Neuroblastoma Vaccine (unmodified SKNLP, with gene-modified SJNB-JF-IL2 and SJNB-JF-LTN neuroblastoma cells
- Cytoxan
-
Houston, TexasTexas Children's Hospital
Mar 25, 2022
Neuroblastoma Trial in Houston (SNJB-JF-IL2 and SJNB-JF-Lptn + Dose Level 1 SKNLP, SNJB-JF-IL2 and SJNB-JF-Lptn + Dose Level 2
Active, not recruiting
- Neuroblastoma
- SNJB-JF-IL2 and SJNB-JF-Lptn + Dose Level 1 SKNLP
- SNJB-JF-IL2 and SJNB-JF-Lptn + Dose Level 2 SKNLP
-
Houston, TexasTexas Children's Hospital
Mar 3, 2022
Neuroblastoma Trial in Houston (EBV specific CTLs)
Active, not recruiting
- Neuroblastoma
- EBV specific CTLs
-
Houston, TexasTexas Children's Hospital
Feb 2, 2022
Neuroblastoma, Neuroectodermal Tumors, Tumors Trial in United States (131I-MIBG, 131-MIBG + Vorinostat)
Recruiting
- Neuroblastoma
- +2 more
- 131I-MIBG
- 131-MIBG + Vorinostat
-
San Francisco, California
- +15 more
Jan 7, 2022
Neuroblastoma, CNS Metastases, Leptomeningeal Metastases Trial in Worldwide (131I-omburtamab)
Recruiting
- Neuroblastoma
- +2 more
- 131I-omburtamab
-
Los Angeles, California
- +11 more
Dec 17, 2021
Pediatric Solid Tumor, Pediatric Lymphoma, Pediatric Brain Tumor Trial in Australia, Canada, United States (CLR 131)
Recruiting
- Pediatric Solid Tumor
- +7 more
- CLR 131
-
Palo Alto, California
- +6 more
Nov 30, 2021
Osteosarcoma, Neuroblastoma Trial in Houston (genetic, biological, drug)
Active, not recruiting
- Osteosarcoma
- Neuroblastoma
- GD2 T cells
- +3 more
-
Houston, Texas
- +1 more
Apr 16, 2021